Starbucks CEO transition plan gets muted reaction from Wall Street

Starbucks CEO transition plan gets muted reaction from Wall Street


“As we create more premium beverages, it becomes more difficult for customers to replicate it at home and we think that helps with the concept of trade down,” Starbucks CFO Rachel Ruggeri told CNBC’s “Squawk Box” on Aug. 3.

Gary Hershorn / Contributor / Getty Images

Wall Street’s reaction to Starbucks’ new CEO was muted Friday morning, with shares down about 1% after the coffee company named restaurant industry outsider Laxman Narasimhan as its next leader.

Narasimhan will join the company in October before stepping into the top job in April, Starbucks announced late Thursday. He will succeed interim chief executive Howard Schultz, who returned to Starbucks for his third stint earlier this year. Schultz will stay on as an advisor and remain on the board. BTIG analyst Peter Saleh compared the structure to a co-CEO model in a note to clients.

Now, all eyes are on Starbucks’ investor day in Seattle on Sept. 13.

“Importantly, this hire removes a major overhang for [Starbucks] shares, with focus now shifting to the ’22 Investor Day,” Barclays analyst Jeffrey Bernstein wrote.

The company is expected to unveil a reinvention plan that will bring bold changes to the chain and its cafes. Schultz has crafted the strategy and will remain heavily involved with its implementation.

Previous Schultz departures have resulted in double-digit tumbles for Starbucks stock. When the company announced in late 2016 that then-Chief Operating Officer Kevin Johnson would replace Schultz, shares fell as much as 10% in extended trading. Johnson was a relative newcomer to the restaurant industry, joining Starbucks as COO after decades working in tech.

But Wall Street doesn’t seem very concerned about Starbucks’ latest transition plan. When the company announced its incoming CEO Thursday evening, the stock fell less than 1% in extended trading. In a demonstration of investors’ trust in Narasimhan, shares of his current employer, Lysol and Durex owner Reckitt, fell as much as 5.7% on Thursday after the surprise announcement of his departure later this month.

“Narasimhan joins from Reckitt where he has overseen a successful restructuring, likely invaluable experience for the reinvention Schultz clearly envisages for [Starbucks],” Atlantic Equities analyst Edward Lewis said in a Friday note.

Analysts focused on Narasimhan’s global experience, which could strengthen Starbucks’ sales in emerging markets. His previous roles included serving as head of PepsiCo’s Latin America, Europe and sub-Saharan Africa operations.

Narasimhan “brings the right kind of fresh perspective, leadership capabilities and energy” to take Starbucks to the next level, Jefferies analyst Andy Barish wrote.

Starbucks' new CEO Laxman Narasimhan takes helm in April 2023



Source

How Domino’s is trying to double its business during a rough patch for big pizza rivals
Business

How Domino’s is trying to double its business during a rough patch for big pizza rivals

In this photo illustration, a Domino’s pizza sits in a take-out box on July 21, 2025 in Miami, Florida. Joe Raedle | Getty Images Domino’s Pizza shares climbed on a Monday after the company posted a better-than-expected quarter and laid out ambitious growth plans. The strong performance came as the pizza chain said it saw […]

Read More
Mortgage rates just dropped below 6%, matching lowest level since 2022
Business

Mortgage rates just dropped below 6%, matching lowest level since 2022

A stock market sell-off had investors rushing to the relative safety of the bond market Monday morning, causing yields to drop and mortgage rates to follow. The average rate on the popular 30-year fixed mortgage fell to 5.99% on Monday, according to Mortgage News Daily, matching its lowest levels since 2022. Last year at this […]

Read More
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Business

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. Cash-paying patients can […]

Read More